Sawai Pharmaceutical Co., Ltd. Stock price Japan Exchange
Equities
4555
JP3323050009
Pharmaceuticals
Sales 2024 * | 202B 1.33B | Sales 2025 * | 206B 1.36B | Capitalization | 259B 1.71B |
---|---|---|---|---|---|
Net income 2024 * | 19.42B 128M | Net income 2025 * | 17.19B 114M | EV / Sales 2024 * | 1.45 x |
Net Debt 2024 * | 34.69B 229M | Net Debt 2025 * | 39.72B 262M | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
15
x | Employees | 3,393 |
Yield 2024 * |
2.2% | Yield 2025 * |
2.31% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
President | 66 | 21-03-31 | |
Toru Terashima
BRD | Director/Board Member | 64 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 21-03-31 |
Kenzo Sawai
BRD | Director/Board Member | 55 | 21-03-31 |
Masatoshi Ohara
BRD | Director/Board Member | 72 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |